Atlanta Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Atlanta Capital Management's IDXX Position: Q3 2022 in Review
Atlanta Capital Management increased its Idexx Laboratories (IDXX) stake by 6.1% in Q3 2022, buying an estimated $3.18M and bringing the position to 149,879 shares worth $48.8M. The position accounts for 0.22% of the portfolio, ranked #109.
Atlanta Capital Management first reported a position in IDXX in Q2 2013 and has held it in 19 quarters since. The position peaked at $260M in Q4 2016. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.
- Atlanta Capital Management held 149,879 shares of Idexx Laboratories worth $48.8M as of Q3 2022.
- Atlanta Capital Management bought 8,666 Idexx Laboratories shares in Q3 2022, an estimated $3.18M.
- Idexx Laboratories made up 0.22% of Atlanta Capital Management's portfolio in Q3 2022, its #109 holding.
- Atlanta Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 19 quarters since.
- Atlanta Capital Management's Idexx Laboratories position peaked at $260M in Q4 2016.
- 925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.
Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.